SENS
Senseonics Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.58
+1.59%Sep 14, 2026, 11:00 UTC
Senseonics Holdings announced a strategic partnership with Beta Bionics to integrate the Eversense 365 continuous glucose monitoring system with the iLet Bionic Pancreas, with a planned commercial launch in Q4 2026.
Source:Aug 6, 2026, 00:00 UTC
Senseonics Holdings reported Q2 2026 revenue of $14.5 million, a 120% increase year-over-year, with a net loss of $36.7 million.
Jun 11, 2026, 18:11 UTC
Senseonics (SENS) partners with Welldoc to develop a next-generation Eversense 365 app with Apple Health and Google Health Connect integration ahead of the U.S. launch.
Source:May 4, 2026, 00:00 UTC
Senseonics Holdings, Inc. amended its senior secured term loan facility, providing up to $140 million in loans due September 3, 2029, with an initial $35 million tranche funded at closing on May 6, 2026.